FDA Inspection
AstraZeneca ABAstraZeneca AB – FDA Inspection, Apr 10, 2026
Record Details
This FDA Inspection record concerns AstraZeneca AB, with an inspection on April 10, 2026, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 45e505d2-6072-4063-8327-80b89d82e448
Inspection Facts
- Inspection number
- 1318264
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of AstraZeneca AB
10| Date | Classification | Office | Project area |
|---|---|---|---|
| November 13, 2025 | NAI | Postmarket Assurance: Devices | |
| December 1, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 6, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 11, 2018 | VAI | Office of Inspections and Investigations | New Drug Evaluation |
| December 7, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for AstraZeneca AB
- FDA Inspection 1295446 - 2025-11-13
- FDA Inspection 1248230 - 2022-12-01
- FDA Inspection 1143443 - 2019-12-06
- FDA Inspection 1068727 - 2018-10-11
- FDA Inspection 1115572 - 2017-12-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.